Project Management for Drug Developers, First Edition" edited by Joseph P. Stalder is a must-have for seasoned project, program, and portfolio leaders in the biopharma industry, for recent graduates embarking on careers in drug development project management, and professionals transitioning into project management roles within the biopharma sector. This comprehensive resource provides insights into the essential role of project management, explores contemporary themes in drug development, and presents a robust framework for project management known as GRIDALL.
Having utilized and endorsed this book while mentoring junior project managers, I can attest to its clarity in outlining the typical drug development process, emphasizing the importance of project management methodologies at each phase, and defining the functions and accountabilities of project teams. Noteworthy chapters cover topics such as the project management office, project portfolio management, agile project management, international project management, and the utilization of technology and project management information systems. These chapters establish a solid groundwork for organizations progressing towards greater operational complexity and maturity, broadening their asset development pipeline, or engaging in global initiatives.
Furthermore, the authors provide practical, real-world advice on crafting asset development plans, clinical development plans, market application submissions, and a comprehensive project management framework. This guidance proves invaluable for swiftly formulating plans or assuming responsibilities for new projects.
I wholeheartedly endorse this book and am confident that, like me, you will frequently turn to its pages for guidance and insight (as evidenced by my well-thumbed copy).
Stephen Smith
Senior Program Director
Corcept Therapeutics
